Ex-Ante-Transparenzbekanntmachung § 130a Abs. 8 SGB V Arzneimittelbezeichnung: ATC-Code B02BD02; B02BD04

Deadline:N/A

We were not able to find a link to the source, please find contact details in the documents.

Tender information

Germany

Type

Voluntary ex ante transparency

Procedure

Negotiated without a call for competition

Ref. number

26-079

Duration

2 years

Arzneimittelrabattvertrag § 130a Abs. 8 SGB V Arzneimittelbezeichnung: HAEMOCTIN SDH (R), Blutgerinnungsfaktor VIII ATC-Code B02BD02; HAEMONINE(R), Blutgerinnungsfaktor IX ATC-Code B02BD04

Buyer

AOK Bayern - Die Gesundheitskasse

Documents

Document name	Upload date	File size
First document.pdf	1 Jan 1970, 00:00	1 Bytes
Second document.pdf	1 Jan 1970, 00:00	1 Bytes

Information on this page originates from the following sources: TED

Buyer

AOK Bayern - Die Gesundheitskasse

No time limit

Important dates

24 Jul - Publication date

Unlock Full Access with Mercell Bidding Business Plus

Start your free trial to explore exclusive features that help you win more tenders, faster:

AI-Powered Tender Insights

Buyer Contact Info

Key Tender Timelines

Already have an account?

We were not able to find a link to the source, please find contact details in the documents.

Ex-Ante-Transparenzbekanntmachung § 130a Abs. 8 SGB V Arzneimittelbezeichnung: ATC-Code B02BD02; B02BD04

Documents

Your privacy is important to us